Fa'amatalaga
O la matou Omeprazole intermediate 2.3.5-Trimethyl-4-nitropyridine-N-oxide o loʻo gaosia ma le faʻaeteete ina ia ausia tulaga maualuga o alamanuia, faʻamautinoaina lona mama ma le aoga ma e mafai ona faʻaaogaina i le tele o vailaʻau ma vailaʻau.Faatasi ai ma lona tuufaatasiga saʻo ma uiga faʻapitoa, o lenei tuufaatasiga o se filifiliga lelei mo tagata suʻesuʻe, saienitisi ma fomaʻi faʻapolofesa o loʻo suʻeina ni tagata faʻalagolago, maualuga-faʻatinoga mo a latou poloketi.
E taua tele le sao o lenei vailaʻau i le gaosiga o le omeprazole, o se vailaʻau e masani ona faʻaaogaina e togafitia ai faʻamaʻi pipisi e pei o le gastroesophageal reflux disease (GERD), peptic ulcers, ma le zolin (Guardian-Ellison syndrome).I le avea ai o se vaega autu i le tuʻufaʻatasia o le omeprazole, o le matou omeprazole intermediate 2.3.5-trimethyl-4-nitropyridine-N-oxide e faʻafaigofieina le gaosiga lelei ma le taugofie o lenei vailaʻau taua.
Filifili Matou
O le JDK o lo'o i ai le vaega muamua o le gaosiga o fale ma meafaigaluega tau pulega lelei, lea e fa'amautinoa ai le tu'uina atu o le API intermediates.'Au fa'apolofesa fa'amautinoa le R&D o le oloa.Faʻasaga ia lua, o loʻo matou suʻeina CMO & CDMO i maketi i totonu o le atunuʻu ma faavaomalo.